Albert Burla, CEO of Pfizer, a giant drug maker, said that a new medicine that treats the Coronavirus (also known as COVID-19) and is taken by the mouth may be produced and introduced to the markets across the world by the end of the next year.
Burla added during statements made today, Wednesday to the US Al-Hurra satellite channel that experts of the company are working now on two medicines: the first is administrated by the mouth and the second one taken by injection.
The CEO of Pfizer revealed that the company began an early phase of clinical trials for an oral drug late last month, and the drug blocks the "protease", an important enzyme that the virus needs to reproduce when it invades the human body.
And Burla continued, "We pay special attention to the oral drug because it provides many advantages, one of which is that you do not need to go to the hospital for treatment so you can get it at home."
Also, he added that the oral drug needs no special medical procedures like the injected one.
No trained crews should be on the spot to handle the drug and it could be distributed in the poor and underdeveloped countries without any impediments.
He also said that the drug could be "a more effective method against multiple mutations that appeared in various parts of the planet which present complicated challenges to scientists.
Burla indicated that the company will have more news about this development later in the summer of this year, and Pfizer developed the anti-Covid-19 vaccine jointly with the German pharmaceutical company Biontech, which the Food and Drug Administration (FDA) granted an emergency license in December, and it is one of the three vaccines. Against disease currently approved for use in the United States of America (USA).
Follow the latest news on Google News
